Originator
Sources: https://pubs.acs.org/doi/10.1021/jo01362a017
Curator's Comment: reference retrieved from https://www.drugfuture.com/chemdata/metazocine.html
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. | 2002 Nov 18 |
|
Activity of opioid ligands in cells expressing cloned mu opioid receptors. | 2003 Jan 4 |
|
Migratory hydroamination: a facile enantioselective synthesis of benzomorphans. | 2003 Jul 23 |
|
Pharmacological profiles of opioid ligands at kappa opioid receptors. | 2006 Jan 25 |
|
Catalytic enantioselective amination of silyl enol ethers using chiral dirhodium(II) carboxylates: asymmetric formal synthesis of (-)-metazocine. | 2007 Oct 25 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9240
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90175554
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
C96731
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
C047238
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
223-097-3
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
45479834
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | PUBCHEM | ||
|
SUB08820MIG
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
942
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
METAZOCINE
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
XD53YGT34W
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
m7275
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | Merck Index | ||
|
3734-52-9
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
100000081220
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL257661
Created by
admin on Sat Dec 16 18:11:14 GMT 2023 , Edited by admin on Sat Dec 16 18:11:14 GMT 2023
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY
SALT/SOLVATE (PARENT)